Association of body mass index with removal of etonogestrel subdermal implant.

[1]  L. Finer,et al.  Unintended pregnancy in the United States: incidence and disparities, 2006. , 2011, Contraception.

[2]  Petra M. Casey,et al.  Bleeding related to etonogestrel subdermal implant in a US population. , 2011, Contraception.

[3]  I. Fraser,et al.  The effects of Implanon® on menstrual bleeding patterns , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[4]  Rongxiu Li,et al.  RETRACTED: Doxycycline alters the expression of matrix metalloproteases in the endometrial cells exposed to ovarian steroids and pro-inflammatory cytokine. , 2007, Journal of reproductive immunology.

[5]  L. Finer,et al.  Perspectives on sexual and reproductive health , 2002 .

[6]  C. Robinson,et al.  An assessment of the first 3 years' use of Implanon® in Luton , 2005, Journal of Family Planning and Reproductive Health Care.

[7]  D. Mishell,et al.  Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. , 2005, Contraception.

[8]  M. Luna,et al.  Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. , 2001, Contraception.

[9]  P. Wannakrairot,et al.  The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users. , 1996, Human reproduction.

[10]  P. Rogers,et al.  Oestrogen treatment for increased bleeding in Norplant users: preliminary results. , 1996, Human reproduction.

[11]  Qiao-zhi Yang,et al.  Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. , 1996, Contraception.